{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T16:19:20Z","timestamp":1791389960767,"version":"4.3.3"},"reference-count":77,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2009,8,1]],"date-time":"2009-08-01T00:00:00Z","timestamp":1249084800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Seminars in Arthritis and Rheumatism"],"published-print":{"date-parts":[[2009,8]]},"DOI":"10.1016\/j.semarthrit.2008.05.002","type":"journal-article","created":{"date-parts":[[2008,7,14]],"date-time":"2008-07-14T19:02:50Z","timestamp":1216062170000},"page":"18-29","source":"Crossref","is-referenced-by-count":128,"title":["Serum Immunoglobulins and Risk of Infection: How Low Can You Go?"],"prefix":"10.1016","volume":"39","author":[{"given":"Daniel E.","family":"Furst","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.semarthrit.2008.05.002_bib1","doi-asserted-by":"crossref","first-page":"2572","DOI":"10.1056\/NEJMoa032534","article-title":"Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis","volume":"350","author":"Edwards","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.semarthrit.2008.05.002_bib2","doi-asserted-by":"crossref","first-page":"2146","DOI":"10.1002\/art.11181","article-title":"Serologic changes following B lymphocyte depletion therapy for rheumatoid arthritis","volume":"48","author":"Cambridge","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2008.05.002_bib3","doi-asserted-by":"crossref","first-page":"133","DOI":"10.3949\/ccjm.73.2.133","article-title":"Evaluating and managing hypogammaglobulinemia","volume":"73","author":"Rose","year":"2006","journal-title":"Cleve Clin J Med"},{"key":"10.1016\/j.semarthrit.2008.05.002_bib6","first-page":"418","article-title":"IgG deficiency in adults with recurrent respiratory infections","volume":"70","author":"Popa","year":"1993","journal-title":"Ann Allergy"},{"key":"10.1016\/j.semarthrit.2008.05.002_bib7","first-page":"703","article-title":"Serum IgG subclasses in chronic and recurrent respiratory infections","volume":"58","author":"Stanley","year":"1984","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.semarthrit.2008.05.002_bib8","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1203\/01.PDR.0000099776.66136.39","article-title":"Immunoglobulins in otitis-prone children","volume":"55","author":"Veenhoven","year":"2004","journal-title":"Pediatr Res"},{"key":"10.1016\/j.semarthrit.2008.05.002_bib9","first-page":"69","article-title":"IgA and\/or IgG subclass deficiency in children with recurrent respiratory infections and its relationship with chronic pulmonary damage","volume":"15","author":"Ozkan","year":"2005","journal-title":"J Investig Allergol Clin Immunol"},{"key":"10.1016\/j.semarthrit.2008.05.002_bib10","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1002\/path.1877","article-title":"The function of immunoglobulin A in immunity","volume":"208","author":"Woof","year":"2006","journal-title":"J Pathol"},{"key":"10.1016\/j.semarthrit.2008.05.002_bib11","author":"Birdsall"},{"key":"10.1016\/j.semarthrit.2008.05.002_bib12","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/S1081-1206(10)63188-2","article-title":"Clinical manifestations of IgE hypogammaglobulinemia","volume":"78","author":"Smith","year":"1997","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"Suppl A","key":"10.1016\/j.semarthrit.2008.05.002_bib13","doi-asserted-by":"crossref","first-page":"S225","DOI":"10.1016\/S1526-0542(04)90043-7","article-title":"Pulmonary complications of primary immunodeficiencies","volume":"5","author":"Buckley","year":"2004","journal-title":"Paediatr Respir Rev"},{"key":"10.1016\/j.semarthrit.2008.05.002_bib14","first-page":"2001","article-title":"Primary immunodeficiencies","volume":"68","author":"Cooper","year":"2003","journal-title":"Am Fam Physician"},{"key":"10.1016\/j.semarthrit.2008.05.002_bib15","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1007\/s10875-007-9103-1","article-title":"Population prevalence of diagnosed primary immunodeficiency diseases in the United States","volume":"27","author":"Boyle","year":"2007","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.semarthrit.2008.05.002_bib16","author":"Chin"},{"key":"10.1016\/j.semarthrit.2008.05.002_bib17","author":"Makhoul"},{"key":"10.1016\/j.semarthrit.2008.05.002_bib18","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1067\/mai.2002.122466","article-title":"Primary immunodeficiency disorders: antibody deficiency","volume":"109","author":"Ballow","year":"2002","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.semarthrit.2008.05.002_bib19","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1097\/01.md.0000229482.27398.ad","article-title":"X-linked agammaglobulinemia: report on a United States registry of 201 patients","volume":"85","author":"Winkelstein","year":"2006","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.semarthrit.2008.05.002_bib20","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/S0022-3476(99)70246-5","article-title":"Early and prolonged intravenous immunoglobulin replacement therapy in childhood agammaglobulinemia: a retrospective survey of 31 patients","volume":"134","author":"Quartier","year":"1999","journal-title":"J Pediatr"},{"key":"10.1016\/j.semarthrit.2008.05.002_bib21","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0928-8244(03)00304-3","article-title":"Efficacy of intravenous immunoglobulin on the prevention of pneumonia in patients with agammaglobulinemia","volume":"40","author":"Aghamohammadi","year":"2004","journal-title":"FEMS Immunol Med Microbiol"},{"key":"10.1016\/j.semarthrit.2008.05.002_bib22","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.semarthrit.2006.09.005","article-title":"Common variable immunodeficiency in systemic lupus erythematosus","volume":"36","author":"Fernandez-Castro","year":"2007","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2008.05.002_bib23","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/0049-0172(93)80073-O","article-title":"Hypogammaglobulinemia and rheumatic disease","volume":"22","author":"Lee","year":"1993","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2008.05.002_bib24","author":"Cunningham-Rundles"},{"key":"10.1016\/j.semarthrit.2008.05.002_bib25","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1128\/CDLI.12.7.825-832.2005","article-title":"Clinical and immunological features of 65 Iranian patients with common variable immunodeficiency","volume":"12","author":"Aghamohammadi","year":"2005","journal-title":"Clin Diag Lab Immunol"},{"key":"10.1016\/j.semarthrit.2008.05.002_bib26","first-page":"418","article-title":"IgG deficiency in adults with recurrent respiratory infections","volume":"70","author":"Popa","year":"1993","journal-title":"Ann Allergy"},{"key":"10.1016\/j.semarthrit.2008.05.002_bib27","first-page":"49","article-title":"Clinical relevance of IgG subclass deficiencies","volume":"52","author":"Morell","year":"1994","journal-title":"Ann Biol Clin (Paris)"},{"key":"10.1016\/j.semarthrit.2008.05.002_bib28","first-page":"239","article-title":"The efficacy of immunoglobulin replacement therapy in the long-term follow-up of the B-cell deficiencies (XLA, HIM, CVID)","volume":"47","author":"Bayrakci","year":"2005","journal-title":"Turk J Pediatr"},{"key":"10.1016\/j.semarthrit.2008.05.002_bib29","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1111\/j.1398-9995.2005.00756.x","article-title":"Intravenous immunoglobulin replacement prevents severe and lower respiratory tract infections, but not upper respiratory tract and non-respiratory infections in common variable immune deficiency","volume":"60","author":"Favre","year":"2005","journal-title":"Allergy"},{"key":"10.1016\/j.semarthrit.2008.05.002_bib30","first-page":"114","article-title":"Effect of regular intravenous immunoglobulin therapy on prevention of pneumonia in patients with common variable immunodeficiency","volume":"39","author":"Pourpak","year":"2006","journal-title":"J Microbiol Immunol Infect"},{"key":"10.1016\/j.semarthrit.2008.05.002_bib31","doi-asserted-by":"crossref","first-page":"165","DOI":"10.7326\/0003-4819-135-3-200108070-00008","article-title":"The effect of two different dosages of intravenous immunoglobulin on the incidence of recurrent infections in patients with primary hypogammaglobulinemia","volume":"135","author":"Eijkhout","year":"2001","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.semarthrit.2008.05.002_bib32","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1097\/00006454-199707000-00012","article-title":"Human intravenous immunoglobulin in primary and secondary antibody deficiencies","volume":"16","author":"Stiehm","year":"1997","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.semarthrit.2008.05.002_bib33","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1136\/jcp.55.8.577","article-title":"Survey of infection in patients receiving antibody replacement treatment for immune deficiency","volume":"55","author":"Pettit","year":"2002","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.semarthrit.2008.05.002_bib34","author":"Bascom"},{"key":"10.1016\/j.semarthrit.2008.05.002_bib35","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1136\/jcp.54.5.337","article-title":"IgA deficiency: what we should\u2014or should not\u2014be doing","volume":"54","author":"Lilic","year":"2001","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.semarthrit.2008.05.002_bib36","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s10875-006-8144-1","article-title":"Infants presenting with recurrent infections and low immunoglobulins: characteristics and analysis of normalization","volume":"26","author":"Whelan","year":"2006","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.semarthrit.2008.05.002_bib37","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1067\/mpd.2000.109791","article-title":"Preterm infants with low immunoglobulin G levels have increased risk of neonatal sepsis but do not benefit from prophylactic immunoglobulin G","volume":"137","author":"Sandberg","year":"2000","journal-title":"J Pediatr"},{"key":"10.1016\/j.semarthrit.2008.05.002_bib38","author":"Hussain"},{"key":"10.1016\/j.semarthrit.2008.05.002_bib39","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1016\/S0031-3955(05)70269-8","article-title":"Antibody deficiency syndromes","volume":"47","author":"Sorensen","year":"2000","journal-title":"Pediatr Clin North Am"},{"key":"10.1016\/j.semarthrit.2008.05.002_bib40","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1097\/00007890-200101270-00013","article-title":"Hypogammaglobulinemia in lung transplant recipients","volume":"71","author":"Goldfarb","year":"2001","journal-title":"Transplantation"},{"key":"10.1016\/j.semarthrit.2008.05.002_bib41","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S1053-2498(00)00331-4","article-title":"Hypogammaglobulinemia following cardiac transplantation: a link between rejection and infection","volume":"20","author":"Yamani","year":"2001","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.semarthrit.2008.05.002_bib42","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1111\/j.1399-3062.2006.00136.x","article-title":"IgG monitoring to identify the risk for development of infection in heart transplant recipients","volume":"8","author":"Sarmiento","year":"2006","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.semarthrit.2008.05.002_bib43","doi-asserted-by":"crossref","first-page":"4046","DOI":"10.1016\/j.transproceed.2005.09.153","article-title":"Decreased levels of serum immunoglobulins as a risk factor for infection after heart transplantation","volume":"37","author":"Sarmiento","year":"2005","journal-title":"Transplant Proc"},{"key":"10.1016\/j.semarthrit.2008.05.002_bib44","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1046\/j.1526-0968.2000.004005363.x","article-title":"Immunoadsorption for the treatment of rheumatoid arthritis: final results of a randomized trial","volume":"4","author":"Furst","year":"2000","journal-title":"Ther Apher"},{"key":"10.1016\/j.semarthrit.2008.05.002_bib45","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.jbspin.2004.02.009","article-title":"Protein A-immunoadsorption (Prosorba column) in the treatment of rheumatoid arthritis","volume":"72","author":"Poullin","year":"2005","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.semarthrit.2008.05.002_bib46","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1046\/j.1526-0968.2003.00040.x","article-title":"Immunoadsorption in systemic lupus erythematosus: different techniques and their current role in medical therapy","volume":"7","author":"Gaubitz","year":"2003","journal-title":"Ther Apher Dial"},{"key":"10.1016\/j.semarthrit.2008.05.002_bib47","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1517\/13543784.9.9.2017","article-title":"Immunoadsorption, current status and future developments","volume":"9","author":"Braun","year":"2000","journal-title":"Expert Opin Investig Drugs"},{"key":"10.1016\/j.semarthrit.2008.05.002_bib48","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1046\/j.1526-0968.2001.005002084.x","article-title":"Immunoglobulin binding properties of the Prosorba immunadsorption column in treatment of rheumatoid arthritis","volume":"5","author":"Sasso","year":"2001","journal-title":"Ther Apher"},{"key":"10.1016\/j.semarthrit.2008.05.002_bib49","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1093\/rheumatology\/40.5.513","article-title":"Intravenous immunoglobulin application following immunoadsorption: benefit or risk in patients with autoimmune diseases?","volume":"40","author":"Schmaldienst","year":"2001","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.semarthrit.2008.05.002_bib50","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1007\/s00508-004-0232-8","article-title":"Immunoadsorption (IAS) as a rescue therapy in SLE: considerations on safety and efficacy","volume":"116","author":"Stummvoll","year":"2004","journal-title":"Wien Klin Wochenschr"},{"key":"10.1016\/j.semarthrit.2008.05.002_bib51","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.4065\/75.10.1039","article-title":"Infection and immunity in chronic lymphocytic leukemia","volume":"75","author":"Tsiodras","year":"2000","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.semarthrit.2008.05.002_bib52","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s00282-999-0145-0","article-title":"Infectious complications in chronic lymphocytic leukaemia","volume":"41","author":"Morra","year":"1999","journal-title":"Hematol Cell Ther"},{"key":"10.1016\/j.semarthrit.2008.05.002_bib53","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1002\/1097-0142(19880115)61:2<279::AID-CNCR2820610215>3.0.CO;2-4","article-title":"Serum immunoglobulins in B-chronic lymphocytic leukemia","volume":"61","author":"Rozman","year":"1988","journal-title":"Cancer"},{"key":"10.1016\/j.semarthrit.2008.05.002_bib54","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/s11864-001-0037-1","article-title":"Infectious complications in chronic lymphoid malignancy","volume":"2","author":"Egerer","year":"2001","journal-title":"Curr Treat Options Oncol"},{"key":"10.1016\/j.semarthrit.2008.05.002_bib55","first-page":"438","article-title":"Infections in patients with hematological cancer: recent developments","author":"O'Brien","year":"2003","journal-title":"Health Econ"},{"key":"10.1016\/j.semarthrit.2008.05.002_bib56","doi-asserted-by":"crossref","first-page":"471","DOI":"10.3109\/10428199409049706","article-title":"IgG subclass levels in patients with B cell chronic lymphocytic leukaemia","volume":"14","author":"Copson","year":"1994","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.semarthrit.2008.05.002_bib57","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1046\/j.1365-2141.2003.04497.x","article-title":"Disease activity and pretreatment, rather than hypogammaglobulinaemia, are major risk factors for infectious complications in patients with chronic lymphocytic leukaemia","volume":"122","author":"Hensel","year":"2003","journal-title":"Br J Haematol"},{"key":"10.1016\/j.semarthrit.2008.05.002_bib58","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1111\/j.1600-0609.1992.tb01805.x","article-title":"Infections and serum IgG levels in patients with chronic lymphocytic leukemia","volume":"48","author":"It\u00e4l\u00e4","year":"1992","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.semarthrit.2008.05.002_bib59","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1111\/j.1365-2249.1992.tb06965.x","article-title":"Predictors of infection in chronic lymphocytic leukaemia (CLL)","volume":"89","author":"Griffiths","year":"1992","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.semarthrit.2008.05.002_bib60","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1002\/cncr.22094","article-title":"The effect of immunoglobulin VH gene mutation status and other prognostic factors on the incidence of major infections in patients with chronic lymphocytic leukemia","volume":"107","author":"Francis","year":"2006","journal-title":"Cancer"},{"key":"10.1016\/j.semarthrit.2008.05.002_bib61","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1056\/NEJM197507032930103","article-title":"Serum immunoglobulins in the nephrotic syndrome","volume":"293","author":"Giangiacomo","year":"1975","journal-title":"N Engl J Med"},{"key":"10.1016\/j.semarthrit.2008.05.002_bib62","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/j.1440-1754.2004.00285.x","article-title":"Clinical profile of children with nephrotic syndrome not on glucorticoid therapy, but presenting with infection","volume":"40","author":"Alwadhi","year":"2004","journal-title":"J Paediatr Child Health"},{"key":"10.1016\/j.semarthrit.2008.05.002_bib63","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/S0272-6386(12)80899-7","article-title":"Risk factors for infection and immunoglobulin replacement therapy in adult nephrotic syndrome","volume":"24","author":"Ogi","year":"1994","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.semarthrit.2008.05.002_bib64","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/0306-3623(86)90010-8","article-title":"Effects of antiepileptic drugs on concentration of serum proteins and immunoglobulins of epileptic patients","volume":"17","author":"Garzon","year":"1986","journal-title":"Gen Pharmacol"},{"key":"10.1016\/j.semarthrit.2008.05.002_bib65","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/s00431-002-1146-y","article-title":"IgG2, IgG4 and IgA deficiency possibly associated with carbamazepine treatment","volume":"162","author":"Kato","year":"2003","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.semarthrit.2008.05.002_bib66","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1111\/j.1528-1157.1988.tb03726.x","article-title":"Carbamazepine: effect on IgG subclasses in epileptic patients","volume":"29","author":"Gilhus","year":"1988","journal-title":"Epilepsia"},{"key":"10.1016\/j.semarthrit.2008.05.002_bib67","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/BF00314330","article-title":"IgG subclasses in epileptic patients treated with phenytoin","volume":"236","author":"Gilhus","year":"1989","journal-title":"J Neurol"},{"key":"10.1016\/j.semarthrit.2008.05.002_bib68","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1111\/j.1440-1819.1998.tb00983.x","article-title":"Hypogammaglobulinemia during antipsychotic therapy","volume":"52","author":"Abe","year":"1998","journal-title":"Psychiatry Clin Neurosci"},{"key":"10.1016\/j.semarthrit.2008.05.002_bib69","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1128\/CDLI.12.4.560-561.2005","article-title":"Oxcarbazepine-induced immunoglobulin deficiency","volume":"12","author":"Knight","year":"2005","journal-title":"Clin Diag Lab Immunol"},{"key":"10.1016\/j.semarthrit.2008.05.002_bib70","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1089\/pai.1988.2.309","article-title":"Steroid-treated asthmatic patients with low levels of IgG have a normal capacity to produce specific antibodies","volume":"2","author":"Katz","year":"1988","journal-title":"Pediatr Asthma Allergy Immunol"},{"key":"10.1016\/j.semarthrit.2008.05.002_bib71","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1016\/S0022-3476(96)70035-5","article-title":"Humoral immunity in steroid-dependent children with asthma and hypogammaglobulinemia","volume":"129","author":"Lack","year":"1996","journal-title":"J Pediatr"},{"key":"10.1016\/j.semarthrit.2008.05.002_bib72","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1159\/000064258","article-title":"Hypogammaglobulinemia in steroid-dependent asthmatics correlates with the daily dose of oral prednisolone","volume":"128","author":"Kawano","year":"2002","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.semarthrit.2008.05.002_bib73","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1007\/s10067-002-0655-4","article-title":"Transient panhypogammaglobulinaemia and B-lymphocyte deficiency in a patient with neuropsychiatric systemic lupus erythematosus after immunosuppressive therapy","volume":"22","author":"Song","year":"2003","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.semarthrit.2008.05.002_bib74","doi-asserted-by":"crossref","first-page":"2825","DOI":"10.1200\/JCO.1998.16.8.2825","article-title":"Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: half of patients respond to a four-dose treatment program","volume":"16","author":"McLaughlin","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.semarthrit.2008.05.002_bib75","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1038\/sj.bmt.1705463","article-title":"Adjuvant rituximab causes prolonged hypogammaglobulinaemia following autologous stem cell transplant for non-Hodgkin's lymphoma","volume":"38","author":"Shortt","year":"2006","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.semarthrit.2008.05.002_bib76","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1182\/blood-2003-12-4331","article-title":"Rituximab administration following autologous stem cell transplantation for multiple myeloma is associated with severe IgM deficiency","volume":"103","author":"Lim","year":"2004","journal-title":"Blood"},{"issue":"Suppl","key":"10.1016\/j.semarthrit.2008.05.002_bib77","first-page":"S149","article-title":"Immunoglobulin levels and infection rates in patients with rheumatoid arthritis treated with repeated courses of rituximab","volume":"56","author":"Genovese","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2008.05.002_bib78","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1093\/rheumatology\/kel393","article-title":"Repeated B lymphocyte depletion with rituximab in rheumatoid arthritis over 7 yrs","volume":"46","author":"Popa","year":"2007","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.semarthrit.2008.05.002_bib79","doi-asserted-by":"crossref","first-page":"4142","DOI":"10.1002\/art.23047","article-title":"Reduced B lymphocyte and immunoglobulin levels after atacicept treatment in patients with systemic lupus erythematosus: Results of a multicenter, phase ib, double-blind, placebo-controlled, dose-escalating trial","volume":"56","author":"Dall'Era","year":"2007","journal-title":"Arthritis Rheum"}],"container-title":["Seminars in Arthritis and Rheumatism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017208000814?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017208000814?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,7]],"date-time":"2020-05-07T00:48:48Z","timestamp":1588812528000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049017208000814"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,8]]},"references-count":77,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,8]]}},"alternative-id":["S0049017208000814"],"URL":"https:\/\/doi.org\/10.1016\/j.semarthrit.2008.05.002","relation":{},"ISSN":["0049-0172"],"issn-type":[{"value":"0049-0172","type":"print"}],"subject":[],"published":{"date-parts":[[2009,8]]}}}